Year: 2011
Type: article
Abstract: Dendritic cells (DCs) are a heterogeneous population of antigen-presenting cells derived from hematopoietic progenitors that bridge the transition between the innate and adaptive immune responses, while maintaining self-tolerance and Th1/Th2 homeostasis, by priming other cells in either an immunogenic or tolerogenic direction. Through their role in both innate and adaptive immunity, DCs play a major part in transplant engraftment and rejection and in graft-versus-host disease (GvHD). Preferentially tolerogenic or immunogenic DC subtypes offer targets for immunotherapy, to optimize transplant success rates and prolong disease-free and overall survival. Cord blood DCs are immature and preferentially tolerogenic, due to maternal-fetal tolerance, leading to better graft acceptance and immune reconstitution and explaining the lower incidence and severity of GvHD in CB transplantation, despite donor-host mismatching. Manipulation of DC maturation and cell loading with tumor-antigens can direct antitumor immunity and target minimal residual disease, as demonstrated for acute myeloid leukemia, optimizing the graft-versus-leukemia effect.
Source: Stem Cells International
DOI: 10.4061/2011/539896
Authors: Marta Isabel Pereira, Artur Paiva
Institution: Unidade Local de Saúde de Coimbra
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: dendritic cells, cord blood transplantation, graft-versus-host disease, tolerogenic dendritic cells, dendritic cell maturation, antigen loading, graft acceptance, immune reconstitution, maternal-fetal immune tolerance, acute myeloid leukemia, graft-versus-leukemia effect, minimal residual disease, antitumor immunity
Open Access status: gold
Estimated APC paid: $2,570
OpenAlex ID: W2102377873
